Ani Pharmaceuticals Inc (ANIP)
R&D to Revenue
5.54%
Quarterly · Period ending:
ANIP R&D to Revenue
Latest reported5.54%period ending
Latest reported5.54%period ending
ANIP Quarterly R&D/Revenue (0.00% → 5.54%)
Latest values, visible window
High-resolution chart · PNG
ANIP r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 761.6309% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |